Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
923.65
5.75 (0.63%) Natco Pharma - Quaterly Results
Date: 27-05-2024
A fair growth of 23.50% in the revenue at Rs. 9648.00 millions was reported in the March 2024 quarter as compared to Rs. 7812.00 millions during year-ago period.The company has announced a 37.39% increase in its profits to Rs . 3491.00 millions for the quarter ended March 2024 compared to Rs. 2541.00 millions in the corresponding quarter in the previous year.Operating profit surged to 4886.00 millions from the corresponding previous quarter of 3452.00 millions.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202403 | 202303 | % Var | 202403 | 202303 | % Var | 202403 | 202303 | % Var | |
| Sales | 9648.00 | 7812.00 | 23.50 | 35689.00 | 23510.00 | 51.80 | 35689.00 | 23510.00 | 51.80 |
| Other Income | 359.00 | 175.00 | 105.14 | 1047.00 | 855.00 | 22.46 | 1047.00 | 855.00 | 22.46 |
| PBIDT | 4886.00 | 3452.00 | 41.54 | 17417.00 | 9302.00 | 87.24 | 17417.00 | 9302.00 | 87.24 |
| Interest | 45.00 | 12.00 | 275.00 | 145.00 | 86.00 | 68.60 | 145.00 | 86.00 | 68.60 |
| PBDT | 4841.00 | 3440.00 | 40.73 | 17272.00 | 9216.00 | 87.41 | 17272.00 | 9216.00 | 87.41 |
| Depreciation | 516.00 | 376.00 | 37.23 | 1719.00 | 1509.00 | 13.92 | 1719.00 | 1509.00 | 13.92 |
| PBT | 4325.00 | 3064.00 | 41.16 | 15553.00 | 7707.00 | 101.80 | 15553.00 | 7707.00 | 101.80 |
| TAX | 834.00 | 523.00 | 59.46 | 2487.00 | 1336.00 | 86.15 | 2487.00 | 1336.00 | 86.15 |
| Deferred Tax | -2.00 | 24.00 | -108.33 | -361.00 | 5.00 | -7320.00 | -361.00 | 5.00 | -7320.00 |
| PAT | 3491.00 | 2541.00 | 37.39 | 13066.00 | 6371.00 | 105.09 | 13066.00 | 6371.00 | 105.09 |
| Equity | 358.00 | 365.00 | -1.92 | 358.00 | 365.00 | -1.92 | 358.00 | 365.00 | -1.92 |
| PBIDTM(%) | 50.64 | 44.19 | 14.61 | 48.80 | 39.57 | 23.34 | 48.80 | 39.57 | 23.34 |